作者
Shaimaa Abdelaziz Abdelmoneim, Malik Sallam, Dina Mohamed Hafez, Ehab Elrewany, Hesham Metwalli Mousli, Elsayed Mohamed Hammad, Sally Waheed Elkhadry, Mohammed Fathelrahman Adam, Amr Abdelraouf Ghobashy, Manal Naguib, Ahmed El-Sayed Nour El-Deen, Narjiss Aji, Ramy Mohamed Ghazy
发表日期
2022/10/13
来源
Tropical medicine and infectious disease
卷号
7
期号
10
页码范围
298
出版商
MDPI
简介
The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-19) booster dose vaccination after completing the primary vaccination series for individuals ≥18 years and most-at-risk populations. This study aimed to estimate the pooled proportion of COVID-19 vaccine booster dose uptake and intention to get the booster dose among general populations and healthcare workers (HCWs). We searched PsycINFO, Scopus, EBSCO, MEDLINE Central/PubMed, ProQuest, SciELO, SAGE, Web of Science, Google Scholar, and ScienceDirect according to PRISMA guidelines. From a total of 1079 screened records, 50 studies were extracted. Meta-analysis was conducted using 48 high-quality studies according to the Newcastle-Ottawa Scale quality assessment tool. Using the 48 included studies, the pooled proportion of COVID-19 vaccine booster dose acceptance among 198,831 subjects was 81% (95% confidence interval (CI): 75–85%, I2 = 100%). The actual uptake of the booster dose in eight studies involving 12,995 subjects was 31% (95% CI: 19–46%, I2 = 100%), while the intention to have the booster dose of the vaccine was 79% (95% CI: 72–85%, I2 = 100%). The acceptance of the booster dose of COVID-19 vaccines among HCWs was 66% (95% CI: 58–74%), I2 = 99%). Meta-regression revealed that previous COVID-19 infection was associated with a lower intention to have the booster dose. Conversely, previous COVID-19 infection was associated with a significantly higher level of booster dose actual uptake. The pooled booster dose acceptance in the WHO region of the Americas, which did not include any actual …
引用总数
学术搜索中的文章
SA Abdelmoneim, M Sallam, DM Hafez, E Elrewany… - Tropical medicine and infectious disease, 2022